Literature DB >> 11344369

Ultrarush immunotherapy in patients with Hymenoptera venom allergy.

F Ruëff, B Przybilla.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11344369     DOI： 10.1067/mai.2001.115138

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  3 in total

1.  Hymenoptera Venom Immunotherapy: Tolerance and Efficacy of an Ultrarush Protocol versus a Rush and a Slow Conventional Protocol.

Authors:  Vincenzo Patella; Giovanni Florio; Ada Giuliano; Carmine Oricchio; Giuseppe Spadaro; Gianni Marone; Arturo Genovese
Journal:  J Allergy (Cairo)       Date:  2012-05-24

2.  Safety and tolerability of venom immunotherapy: Evaluation of 581 rush- and ultra-rush induction protocols (safety of rush and ultra-rush venom immunotherapy).

Authors:  Richard Stock; Tatjana Fischer; Katharina Aẞmus; Nadja Zoeller; Hanns Ackermann; Roland Kaufmann; Markus Meissner; Eva Valesky
Journal:  World Allergy Organ J       Date:  2020-12-15       Impact factor: 4.084

3.  Anaphylactic reactions in the build-up phase of rush immunotherapy for bee venom allergy in pediatric patients: a single-center experience.

Authors:  Antonia Glaeser; Christoph Müller; Sebastian Bode
Journal:  Clin Mol Allergy       Date:  2022-04-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.